Flipping JAKs

About 18 months after Cell Therapeutics Inc. (NASDAQ:CTIC; MILAN:CTIC) acquired pacritinib from S*BIO Pte. Ltd., CTI has flipped the myelofibrosis compound in a deal that provides a much needed cash infusion.